United Therapeutics Corporation Files Lawsuit Alleging Infringement Of Tyvaso Patent Already Found To Be Invalid By U.S. Patent Office
Portfolio Pulse from Benzinga Newsdesk
United Therapeutics Corporation has filed a lawsuit alleging infringement of its Tyvaso patent, which has already been declared invalid by the U.S. Patent Office.
September 06, 2023 | 8:32 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Liquidia Technologies Inc. may be indirectly affected by the lawsuit filed by United Therapeutics Corporation.
While Liquidia Technologies Inc. is not directly mentioned in the article, they may be indirectly affected by the lawsuit filed by United Therapeutics Corporation. The exact impact is uncertain without more specific information.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 50
NEGATIVE IMPACT
United Therapeutics Corporation is involved in a legal dispute over its invalidated Tyvaso patent.
The lawsuit filed by United Therapeutics Corporation could potentially lead to legal costs and reputational damage. The fact that the patent has already been invalidated could weaken their position in the lawsuit, potentially negatively impacting the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100